Status:
COMPLETED
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome
Lead Sponsor:
St. Olavs Hospital
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Breast Neoplasm
Eligibility:
FEMALE
20-100 years
Brief Summary
Breast cancer is the most common cancer among women in Norway. In 2016, 3402 new cases were diagnosed (3371 in women). Breast cancer is still the second most common cause of death from cancer among wo...
Detailed Description
After identifying all patients who were recommended endocrine therapy, data will be linked to the Norwegian Prescription Database (NorPD). Adherence will be estimated based on to which extent the pati...
Eligibility Criteria
Inclusion
- Luminal breast cancer
Exclusion
- Non-Luminal breast cancer
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
1411 Patients enrolled
Trial Details
Trial ID
NCT03761420
Start Date
August 1 2019
End Date
April 1 2021
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Olavs Hospital
Trondheim, Norway